BioSpace News Archive

BioRestorative Therapies, Inc. Schedules Pre-IND Meeting With FDA

November 24, 2014
·
3 min read
Business

Sevion Therapeutics Announces Chimerasome Research Agreement

November 24, 2014
·
1 min read
Pharm Country

NPS Pharmaceuticals, Inc. Release: Teduglutide Granted Orphan Drug Designation In Japan

November 24, 2014
·
5 min read
Policy

Merck & Co. Submits New Drug Application To The Japanese Pharmaceuticals And Medical Devices Agency For Omarigliptin, An Investigational Once-Weekly DPP-4 Inhibitor For Type 2 Diabetes

November 24, 2014
·
4 min read
FDA

Ariad Pharmaceuticals, Inc. And Specialised Therapeutics Australia Announce Approval Of Iclusig (Ponatinib) In Australia

November 24, 2014
·
11 min read
Genetown

Ora-CAC® Model Provided Platform For Recent Positive Phase 2 Data For Ocular Therapeutix, Inc.’s OTX-DP In Allergic Conjunctivitis

November 24, 2014
·
4 min read
Drug Development

Milestone Pharmaceuticals Announces Positive Phase 1 Data For MSP-2017; Supports Advancement Into Phase 2 In PSVT Patients

November 24, 2014
·
3 min read
Policy

IGI Laboratories, Inc. Announces ANDA Submission

November 24, 2014
·
2 min read
Drug Development

INSYS Therapeutics Receives FDA Orphan Drug Designation For Its Pharmaceutical Cannabidiol As A Potential Treatment For Pediatric Schizophrenia

November 24, 2014
·
4 min read
Drug Development

Synthetic Biologics, Inc. Safe-To-Proceed Under IND To Initiate Clinical Trials Of SYN-004 For The Prevention C. Difficile Infection

November 24, 2014
·
6 min read